Search Results
Confidence in the Wake of Natural Disaster
Through remote patient technology, nurses were able to stay connected with peritoneal dialysis patients after an earthquake.
Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury
Baxter International Inc. (NYSE: BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The announcement was made at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week.
Vision-Impaired Patient Tackles Home Dialysis with Confidence
Jeremy values his independence, which helps drive his determination to perform life-sustaining peritoneal dialysis treatments from the comfort of his home in Manitoba, Canada.
Making Positive Impacts on Patients and Families
Our employees are developing products and therapies with our patients' in mind.
Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international). Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 6993043.
Baxter Announces U.S. FDA Approval and Launch of Ready-To-Use Cardiovascular Medicine Eptifibatide
Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.
Baxter Honored as a 2019 'Top Company for Executive Women' By the National Association for Female Executives
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today that it has been named one of the 2019 NAFE Top Companies for Executive Women by the National Association for Female Executives (NAFE). This recognition highlights the company’s efforts to advance women in leadership and foster an inclusive and diverse culture.
